Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/19528449

Download in:

View as

General Info

PMID
19528449